IP Library Granted Patent US 8,440,985
Granted Patent B2
US 8,440,985 · App. 13/000,549 · Granted May 14, 2013

Method and a device for detecting the fluorescence of a biochip

Inventors: Lucio Martinelli (Paris, FR); Yann Marcy (Paris, FR); Henri Benisty (Palaiseau, FR)
Assignee: Genewave
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,440,985
App. No.
13/000,549
Granted
May 14, 2013
Kind
B2
Abstract

An imaging method and a device for detecting the fluorescence of a biochip by illuminating chromophores associated with probes ( 14 ) of a substrate ( 12 ) placed on a sensor ( 10 ) having photodetectors, e.g. of the CCD or CMOS type, a stop filter that rejects the excitation light of the chromophores being provided between the probes ( 14 ) and the sensor, the substrate ( 12 ) being separable from the sensor ( 10 ) after use so as to enable the sensor to be reused.

Claims (21)

1. A method of imaging and detecting the fluorescence emitted by chromophores fixed on a substrate, by illuminating the chromophores at an excitation wavelength and by picking up the light emitted by the chromophores in response to said illumination, said substrate being at least partially transparent at the emission wavelength of the chromophores and carrying biological probes configured to be put into contact with looked-for biological targets, the method being characterized in that it comprises

placing or fastening a fluid flow device on the substrate, the fluid flow device having channels and/or chambers for introducing or circulating fluids,

putting the substrate carrying the fluid flow device into contact with a sensor, while interposing a stop filter between the chromophores and the sensor to reject the excitation wavelength, the filter being transparent at the emission wavelength,

using the fluid flow device to bring biological targets into contact with the probes fastened on the substrate, and

illuminating the substrate at the excitation wavelength of the chromophores, and

using the sensor to detect the light signals emitted by the chromophores.

2. A method according to claim 1 , characterized in that at least partial index continuity is ensured between the substrate and the sensor.

3. A method according to claim 1 , characterized in that an image of the probes is transmitted to the sensor by means of a block or wafer of optical fibers.

4. A method according to claim 1 , characterized in that once the light signals emitted by the chromophores have been acquired, the sensor is separated from the substrate and is reusable with another substrate.

5. A device for imaging and detecting the fluorescence emitted by chromophores fixed on a substrate, by executing the method according to claim 1 , the device comprising a substrate that is at least partially transparent at the emission wavelength of the chromophores and means for imaging, detecting and acquiring the light emitted by the chromophores in response to their light excitation, these means comprising a photo sensor characterized in that it comprises:

a fluid flow device including channels and/or chambers for introducing or circulating fluid, designed to be placed or fastened on the substrate to bring biological targets into contact with the probes fastened on the substrate and placed with the substrate onto the sensor,

a stop filter that rejects the excitation wavelength of the chromophores, mounted between the chromophores and the sensor;

means for putting the substrate into optical contact with the sensor to form an image of the chromophores on the sensor, and enabling the substrate to be separated from the sensor after it has been used.

6. A device according to claim 5 , characterized in that the substrate comprises a thin plate of glass or sapphire, a film of a plastics material, a polarizing filter, a set of optical fibers, or a set of capillary tubes containing the probes.

7. A device according to claim 6 , characterized in that the substrate comprises a plastics material comprising polydimethylsiloxane.

8. A device according to claim 5 , characterized in that the substrate is formed by the stop filter that rejects light at the excitation wavelength.

9. A device according to claim 5 , characterized in that the stop filter comprises an absorbent filter, or a reflective filter, or a combination of absorbent and reflective filters.

10. A device according to claim 5 , characterized in that it includes means providing index continuity between the substrate and the sensor, said means comprising a thin layer of liquid or gel or flexible material of suitable index connecting the substrate to the sensor.

11. A device according to claim 5 , characterized in that the fluid flow device is made of glass by etching or of polymer by molding, thermoforming, or assembling polymer films that include cutouts corresponding to the above-mentioned channels and/or chambers.

12. A device according to claim 5 , wherein the photo sensor comprises a matrix of CCD or CMOS type photodetectors or a photosensitive emulsion.

13. A method according to claim 1 , wherein the sensor comprises a matrix of CCD or CMOS type photodetectors or a photosensitive emulsion.

Assignments (5)
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 075926/0339 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2024
From: GENEWAVE SAS
To: MOBIDIAG OY
Reel/Frame 068501/0630 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2024
From: MOBIDIAG OY
To: GEN-PROBE INCORPORATED
Reel/Frame 068501/0702 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2011
From: MARTINELLI, LUCIO; MARCY, YANN; BENISTY, HENRI
To: GENEWAVE
Reel/Frame 026023/0233 →
Priority Claims (1)
FR 08 03528 · Jun 24, 2008 · national
Continuity (1)
Related Publication 20110266460A1 · Nov 3, 2011